Anqi Li

Anqi Li's research spans molecular mechanisms in cancer, cardiovascular disease, and neurological disorders, with recurring interest in non-coding RNAs (like microRNAs and lncRNAs), cellular metabolism, and toxicology (e.g., benzene exposure and genotoxicity). Recent work has expanded into single-cell transcriptomics, multi-omics approaches, and neurodegenerative disease models such as Alzheimer's and multiple sclerosis. This body of work suggests a broad molecular biology background applied across diverse disease contexts rather than a single narrow specialty.

Publication output has fluctuated over the past decade, with a dip around 2021-2022 followed by a resurgence in 2023 and a notable increase in 2025, averaging about 2-3 papers per year over the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026